Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Altered behavioral responses to gamma‐aminobutyric acid pharmacological agents in a mouse model of Huntington's disease

View through CrossRef
ABSTRACTBackground: Disruptions in gamma‐aminobutyric (GABA) acid signaling are believed to be involved in Huntington's disease pathogenesis, but the regulation of GABAergic signaling remains elusive. Here we evaluated GABAergic signaling by examining the function of GABAergic drugs in Huntington's disease and the expression of GABAergic molecules using mouse models and human brain tissues from Huntington's disease.Methods: We treated wild‐type and R6/2 mice (a transgenic Huntington's disease mouse model) acutely with vehicle, diazepam, or gaboxadol (drugs that selectively target synaptic or extrasynaptic GABAA receptors) and monitored their locomotor activity. The expression levels of GABAA receptors and a major neuron‐specific chloride extruder (potassium‐chloride cotransporter‐2) were analyzed by real‐time quantitative polymerase chain reaction, Western blot, and immunocytochemistry.Results: The R6/2 mice were less sensitive to the sedative effects of both drugs, suggesting reduced function of GABAA receptors. Consistently, the expression levels of α1/α2 and δ subunits were lower in the cortex and striatum of R6/2 mice. Similar results were also found in 2 other mouse models of Huntington's disease and in Huntington's disease patients. Moreover, the interaction and expression levels of potassium‐chloride cotransporter‐2 and its activator (brain‐type creatine kinase) were decreased in Huntington's disease neurons. These findings collectively suggest impaired chloride homeostasis, which further dampens GABAA receptor‐mediated inhibitory signaling in Huntington's disease brains.Conclusions: The dysregulated GABAergic responses and altered expression levels of GABAA receptors and potassium‐chloride cotransporter‐2 in Huntington's disease mice appear to be authentic and may contribute to the clinical manifestations of Huntington's disease patients. © 2017 International Parkinson and Movement Disorder Society
Title: Altered behavioral responses to gamma‐aminobutyric acid pharmacological agents in a mouse model of Huntington's disease
Description:
ABSTRACTBackground: Disruptions in gamma‐aminobutyric (GABA) acid signaling are believed to be involved in Huntington's disease pathogenesis, but the regulation of GABAergic signaling remains elusive.
Here we evaluated GABAergic signaling by examining the function of GABAergic drugs in Huntington's disease and the expression of GABAergic molecules using mouse models and human brain tissues from Huntington's disease.
Methods: We treated wild‐type and R6/2 mice (a transgenic Huntington's disease mouse model) acutely with vehicle, diazepam, or gaboxadol (drugs that selectively target synaptic or extrasynaptic GABAA receptors) and monitored their locomotor activity.
The expression levels of GABAA receptors and a major neuron‐specific chloride extruder (potassium‐chloride cotransporter‐2) were analyzed by real‐time quantitative polymerase chain reaction, Western blot, and immunocytochemistry.
Results: The R6/2 mice were less sensitive to the sedative effects of both drugs, suggesting reduced function of GABAA receptors.
Consistently, the expression levels of α1/α2 and δ subunits were lower in the cortex and striatum of R6/2 mice.
Similar results were also found in 2 other mouse models of Huntington's disease and in Huntington's disease patients.
Moreover, the interaction and expression levels of potassium‐chloride cotransporter‐2 and its activator (brain‐type creatine kinase) were decreased in Huntington's disease neurons.
These findings collectively suggest impaired chloride homeostasis, which further dampens GABAA receptor‐mediated inhibitory signaling in Huntington's disease brains.
Conclusions: The dysregulated GABAergic responses and altered expression levels of GABAA receptors and potassium‐chloride cotransporter‐2 in Huntington's disease mice appear to be authentic and may contribute to the clinical manifestations of Huntington's disease patients.
© 2017 International Parkinson and Movement Disorder Society.

Related Results

North Syrian Mortaria and Other Late Roman Personal and Utility Objects Bearing Inscriptions of Good Luck
North Syrian Mortaria and Other Late Roman Personal and Utility Objects Bearing Inscriptions of Good Luck
<span style="font-size: 11pt; color: black; font-family: 'Times New Roman','serif'">&Pi;&Eta;&Lambda;&Iota;&Nu;&Alpha; &Iota;&Gamma;&Delta...
Functional comparison of Fc epsilon RI, Fc gamma RII, and Fc gamma RIII in mast cells
Functional comparison of Fc epsilon RI, Fc gamma RII, and Fc gamma RIII in mast cells
Abstract The cellular responses initiated by cross-linking rodent Fc gamma RII-b1, Fc gamma RII-b2, Fc gamma RIII, and Fc epsilon RI in mast cells were compared. Ind...
Characterization of the family of dimers associated with Fc receptors (Fc epsilon RI and Fc gamma RIII).
Characterization of the family of dimers associated with Fc receptors (Fc epsilon RI and Fc gamma RIII).
Abstract The receptor for IgE (Fc epsilon RI) is a multimeric complex containing one alpha chain, one beta chain with four transmembrane domains and one homodimer of...
A Method for Determining the Porosity of Pulsed Neutron by Combining Gamma Energy and Time Spectrum
A Method for Determining the Porosity of Pulsed Neutron by Combining Gamma Energy and Time Spectrum
Pulsed-neutron gamma energy spectroscopy and neutron lifetime measurement systems enable the evaluation of the elemental content, saturation. And recent studies have demonstrated t...
Therapeutic advances in neural regeneration for Huntington's disease
Therapeutic advances in neural regeneration for Huntington's disease
Huntington's disease is a neurodegenerative disease caused by the expansion mutation of a cytosine-adenine-guanine triplet in the exon 1 of the HTT ...
Gamma-protocadherin Cis- and Trans-interactions regulate the development of dendrite arbors and synapses in the cerebral cortex
Gamma-protocadherin Cis- and Trans-interactions regulate the development of dendrite arbors and synapses in the cerebral cortex
<p>The alpha-, beta-, and gamma-Protocadherins (gamma-Pcdhs) are cadherin superfamily adhesion molecules encoded by clustered gene families. The 22 gamma-Pcdhs are combinator...

Back to Top